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A B S T R A C T
Geranium robertianum L. is used in folk medicine and herbalism practice for the treatment of a variety of ail-
ments. Recently, we studied the bioactivity of several aqueous and organic extracts of this plant. In this work, the
more active extracts were fractionated and the fractions evaluated for their antioxidant activity and cytotoxicity
against several human tumor cell lines and non-tumor porcine liver primary cells. Some of the fractions from the
acetone extract consistently displayed low EC50 and GI50 values and presented the higher contents of total
phenolic compounds in comparison to other fractions. The phenolic compounds proﬁle of the fractions was
determined. The bio-guided fractionation of the extracts resulted in several fractions with improved bioactivity
relative to the corresponding extracts. Their lower compositional complexity allowed the identiﬁcation of more
than two dozen compounds, to the best of our knowledge, so far not reported in G. robertianum.
1. Introduction
Geranium robertianum L., commonly known as Herb Robert or Red
Robin, belongs to Geraniaceae family and is commonly found in
woodlands, waste lands, roadsides, hedge banks or old walls (Cunha
et al., 2012). Widely spread across Europe, it can also found in Asia,
Africa and America (Allen and Hatﬁeld, 2004). This plant has been used
in folk medicine and herbalism practice for the treatment of a variety of
digestive system disorders, and also as anti-inﬂammatory, haemostatic,
antidiabetic, antibacterial, antiallergic, anti-cancer and diuretic (Graça
et al., 2016a).
As a consequence of the lifestyle, the contemporary society is sub-
jected to continuous exposure to various sources of aggressors which
can provoke an increase in the production of reactive oxygen species
(ROS). Free radicals have been implicated in the onset of various dis-
eases such as cardiovascular diseases, cancer, cataracts, age-related
decline in the immune system, and degenerative diseases. Antioxidants
have the ability to neutralize these species, protecting cells (Aprioku,
2013; Carocho and Ferreira, 2013; Rubió et al., 2013).
G. robertianum contains many biologically active compounds,
mostly polyphenols (Amaral et al., 2009; Fodorea et al., 2005;
Ivancheva and Petrova, 2000; Kartnig and Bucar-Stachel, 1991;
Kobakhidze and Alaniya, 2004; Neagu et al., 2013; Paun et al., 2011,
2012, 2014).
The antioxidant eﬀect of phenolic compounds is mainly due to their
redox properties and their capacity to block the production of ROS such
as superoxide, hydrogen peroxide and hydroxyl, preventing, for ex-
ample, DNA oxidative damage and/or lipid peroxidation (Rubió et al.,
2013). Flavonoids are the main phenolic compounds found in G. ro-
bertianum (Graça et al., 2016a), and their eﬀects on human health are
very often ascribed to their potential ability to act by diminishing free
radical steady-state concentration in biological systems and so pro-
viding antioxidant protection (Galleano et al., 2010).
The antioxidant activity and the cytotoxicity against several human
tumor cell lines and non-tumor porcine liver primary cells of several
aqueous and organic extracts of Geranium robertianum L. were recently
evaluated by our research group (Graça et al., 2016b). In the present
work, the more active extracts − ethyl acetate, acetone and methanol
− were fractionated by gradient elution column chromatography on
silica gel and the resulting fractions were evaluated for their bioactive
properties, namely the antioxidant and antiproliferative properties. The
proﬁle of phenolic compounds of the diﬀerent fractions was determined
and correlated with their bioactivity.
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2. Materials and methods
2.1. Sample
Geranium robertianum L. was collected in França, Serra de
Montesinho, Bragança, Northeastern Portugal, in May 2015. The bo-
tanical identiﬁcation was conﬁrmed by Ana Maria Carvalho from the
Department of Biology and Biotechnology of the School of Agriculture,
Polytechnic Institute of Bragança (Trás-os-Montes, Portugal). Voucher
specimens (ETBO 62 May 2015) are deposited at the herbarium of the
Escola Superior Agrária de Bragança (BRESA). The ethyl acetate,
acetone and methanol extracts were obtained by sequential extraction
of the whole plant, as described previously (Graça et al., 2016b).
2.2. Standards and reagents
Silica gel 0.060–0.200 mm, 60 A was obtained from Acros Organics
(Geel, Belgium). Acetonitrile was of HPLC grade from Fisher Scientiﬁc
(Lisbon, Portugal). Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid), acetic acid, formic acid, ellipticine, sulphorhodamine
B (SRB), trypan blue, trichloroacetic acid (TCA) and Tris was purchased
from Sigma-Aldrich (St. Louis, MO, USA). 2,2-Diphenyl-1-picrylhy-
drazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, MA, USA).
Phenolic compound standards were purchased from Extrasynthèse
(Genay, France). Foetal bovine serum (FBS), L-glutamine, Hank’s ba-
lanced salt solution (HBSS), trypsin-EDTA (ethylenediaminetetraacetic
acid), penicillin/streptomycin solution (100 U/mL and 100 mg/mL,
respectively), RPMI-1640 and DMEM media were from Hyclone (Logan,
UT, USA). Water was treated in a Milli-Q water puriﬁcation system (TGI
Pure Water Systems, Greenville, SC, USA).
2.3. Fractionation of extracts
2.3.1. Ethyl acetate extract
The extract (0.7 g) was dissolved in a minimum of CH2Cl2, mixed
with silica gel, and the mixture evaporated to dryness and placed on the
top of silica gel column. The dry-loaded extract was fractionated by
gradient elution column chromatography using: CH2Cl2; CH2Cl2/EtOAc
− (90:10), (80:20), (70:30), (60:40), (50:50), (40:60), (30:70), (20:80),
(10:90); EtOAc, EtOAc/acetone − (90:10), (80:20), (70:30), (60:40),
(50:50), (60:40), (70:30), (80:20), (90:10); acetone; acetone/MeOH −
(90:10), (80:20), (70:30), (60:40), (50:50), (40:60), (30:70), (20:80),
(10:90); MeOH; MeOH/formic acid (99:1), (97:3), (95:5). Three hun-
dred and eighty two samples (∼23 mL each) were collected and
grouped in eleven fractions (FEA1-11) according to the similarity of
their TLC proﬁles. The solvent of these ﬁnal fractions was removed
under reduced pressure at 40 °C.
2.3.2. Acetone extract
The extract (3 gr) was dissolved in acetone, mixed with silica gel,
and the mixture evaporated to dryness and placed on the top of a silica
gel column. The dry-loaded extract was fractionated by gradient elution
column chromatography using: CH3Cl; CH3Cl/acetone − (90:10),
(80:20), (70:30), (60:40), (50:50), (40:60), (30:70), (20:80), (10:90);
acetone; acetone/MeOH − (90:10), (80:20), (70:30), (60:40), (50:50),
(40:60), (30:7orated to dryness and placed on the top of a silica gel
column. The dry-loaded extract was fractionated by gradient elution
column chromatography using: CH3Cl; CH3Cl/acetone − (90:10),
(80:20), (70:30), (60:40), (50:50), (40:60), (30:70), (20:80), (10:90);
acetone; acetone/MeOH − (90:10), (80:20), (70:30), (60:40), (50:50),
(40:60), (30:7orated to dryness and placed on the top of a silica gel
column. The dry-loaded extract was fractionated by gradient elution
column chromatography using: CH3Cl; CH3Cl/acetone − (90:10),
(80:20), (70:30), (60:40), (50:50), (40:60), (30:70), (20:80), (10:90);
acetone; acetone/MeOH − (90:10), (80:20), (70:30), (60:40), (50:50),
(40:60), (30:70), (20:80), (10:90); MeOH; MeOH/formic acid (99:1),
(97:3), (95:5). Six hundred and seventy-three fractions (∼23 mL each)
were collected and combined on the basis of their TLC proﬁles to yield
eleven ﬁnal fractions (FA1-11) which were evaporated to dryness under
reduced pressure at 40 °C.
2.3.3. Methanol extract
The extract (4 gr) was dissolved in MeOH, mixed with silica gel, and
the mixture evaporated to dryness and placed on the top of a silica gel
column. The dry-loaded extract was fractionated by gradient elution
column chromatography using: CH2Cl2; CH2Cl2/EtOAc − (80:20),
(40:60), (20:80); EtOAc, EtOAc/acetone − (90:10), (80:20), (70:30),
(60:40), (50:50), (40:60), (20:80), (10:90); acetone; acetone/MeOH −
(90:10), (80:20), (70:30), (60:40), (50:50), (40:60), (30:70), (20:80),
(10:90); MeOH; MeOH/formic acid (99:1), (97:3), (95:5). Three hun-
dred and forty three fractions (∼23 mL each) were obtained, checked
by TLC and those with similar band patterns were combined, yielding
thirteen ﬁnal fractions (FM1-13). The solvent was removed at 40 °C
under reduced pressure.
2.4. Phenolic proﬁle of the fractions
The fractions were re-dissolved in water/methanol 80:20 (v/v)
(ﬁnal concentration 5 mg/mL). Phenolic compounds were determined
by high performance liquid chromatography with a diode array de-
tector, coupled to mass spectrometry using the electrospray ionization
interface (HPLC-DAD-ESI/MS), as previously described (Dias et al.,
2013; Roriz et al., 2014). Double online detection was carried out with
a DAD using 280 nm and 370 nm as preferred wavelengths and with a
mass spectrometer (MS) connected to the HPLC system via the DAD cell
outlet. The phenolic compounds were identiﬁed by comparing their
retention time, UV–vis and mass spectra with those obtained from
standard compounds, when available. Otherwise, peaks were tenta-
tively identiﬁed comparing the obtained information with the available
data reported in the literature. For quantitative analysis, a calibration
curve for each available phenolic standard (2 − 100 μg/mL) was con-
structed based on the UV signal. The available phenolic standards are:
chlorogenic acid (y= –161172 + 168823x, r2 = 0.9999); proto-
catechuic acid (y= 27102 + 214168x, r2 = 0.9999); ferulic acid
(y= –185462 + 633126x, r2 = 0.999); p-hydroxibenzoic acid
(y= 173056 + 208604x, r2 = 0.9995); vannilic acid (y= –28661 +
29751x, r2 = 0.9999); caﬀeic acid (y= 406369 + 388345x,
r2 = 0.9939); quercetin-3-O-glucoside (y= –160173 + 34843x,
r2 = 0.9998); ellagic acid (y= –317255 + 26719x, r2 = 0.9986); p-
coumaric acid (y= 6966.7 + 301950x, r2 = 0.9999); quercetin-3-O-
rutinoside (y= 76751 + 13343x, r2 = 0.9998); kaempferol-3-O-ruti-
noside (y= 30861 + 11117x, r2 = 0.9999); naringenin (y=
78903 + 18433x, r2 = 0.9998). For the identiﬁed phenolic compounds
for which a commercial standard was not available, the quantiﬁcation
was performed through the calibration curve of other compound from
the same phenolic group. The results are expressed in mg per g of ex-
tract.
2.5. Evaluation of bioactivity of the fractions
2.5.1. Antioxidant activity
Three diﬀerent in vitro assays were performed using solutions pre-
pared by serial dilution of the stock solutions: scavenging of DPPH (2,2-
diphenyl-1-picrylhydrazyl) radicals, reducing power (measured by fer-
ricyanide Prussian blue assay) and inhibition of β-carotene bleaching as
previously described (Dias et al., 2013; Roriz et al., 2014)
2.5.2. Cytotoxicity in human tumor cell lines and hepatotoxicity in non-
tumor cells
Four human tumor cell lines were tested using solutions prepared by
serial dilution of the stock solutions: MCF-7 (breast adenocarcinoma),
NCI-H460 (non-small cell lung cancer), HeLa (cervical carcinoma) and
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HepG2 (hepatocellular carcinoma), as previously described (Dias et al.,
2013). The hepatotoxicity was evaluated against a non-tumor porcine
liver primary cells (PLP2), as described earlier (Barros et al., 2013; Dias
et al., 2013).
2.6. Statistical analysis
For all the experiments, three samples were analysed and all the
assays were carried out in triplicate. The results are expressed as mean
values ± standard deviation (SD). All statistical tests were performed
at a 5% signiﬁcance level using IBM SPSS Statistics for Windows, ver-
sion 23.0. (IBM Corp., Armonk, NY, USA). The fulﬁlment of the one-
way ANOVA requirements, speciﬁcally the normal distribution of the
residuals (data not shown) and the homogeneity of variance, was tested
by means of the Shapiro Wilk’s and the Levene’s tests, respectively. All
dependent variables were compared using Tukey’s honestly signiﬁcant
diﬀerence (HSD) or Tamhane’s T2 multiple comparison tests, when
homoscedasticity was veriﬁed or not, respectively. Furthermore, a
Pearson’s correlation analysis between the antioxidant activity and all
the analysed compounds was carried out, with a 95% conﬁdence level.
3. Results and discussion
3.1. Analysis of phenolic proﬁle of the fractions
Peak characteristics and tentative identities are presented in Table 1
and the quantiﬁcation of each individual compound present in each
fraction is presented in Tables 2–4.
The most abundant compounds were assigned to hydrolyzable
tannins, being compounds 2, 9, 12, 17, 21, 23, 27 and 35 identiﬁed as
gallotannins composed by two, three, four or ﬁve galloyl moieties
linked to glucose. The mass spectra characteristics of these compounds
consisted of the deprotonated molecule ([M − H]− ions at m/z 483
(compound 2), 635 (compounds 9, 12 and 17), 787 (compounds 21, 23
and 27), and 939 (compound 35), with the loss of one or more galloyl
groups (152 u) and/or gallic acid (170 u). Compounds 14, 15, 18 ([M
− H]− ion at m/z 951) and 30 ([M− H]− ion at m/z 933), which were
abundantly present in the G. robertianum acetone and MeOH extracts,
were tentatively identiﬁed as ellagitannins: three isomers of geraniin
and castalagin/vescalagin (both with the same molecular weight), re-
spectively. The diﬀerent chromatographic retention times of com-
pounds 14, 15 and 18, presenting the same molecular mass, strongly
suggests that they correspond to distinct isomers. These compounds
have also been reported in diﬀerent Geranium species (Okuda et al.,
2000; Tuominen, 2013; Tuominen et al., 2013) and previously reported
by us in G. robertianum (Graça et al., 2016b). Compound 8 ([M−H]− at
m/z 633) was identiﬁed as galloyl-HHDP-glucose, while peaks 19 and
26 ([M−H]− at m/z 785) were coherent with two digalloyl-HHDP-
glucose isomers. The pseudomolecular ion [M − H]− of compound 32
(m/z at 935) might point to a galloyl-bis-HHDP-glucose, although a
diﬀerent fragmentation pattern was described (Dias et al., 2015;
Hanhineva et al., 2008). However, the presence of two HHDP moieties
in its structure was supported by the loss of an HHDP fragment (302 Da,
from the transition 935 > 633), together with the observation of a
product ion at m/z 301. All of these mentioned compounds have al-
ready been described in the previously study G. robertianum (Graça
et al., 2016b).
Peaks 6 and 38 were tentatively associated to ellagitannins, based
on their UV spectra and on the observation of an MS2 fragment ion at
m/z 301 ([HHDP-H]−). Nevertheless, a full identiﬁcation of these
compounds was not possible being identiﬁed as unknown ellagitannins.
Seventeen ﬂavonoid glycosides derivatives were detected nine of
which were kaempferol derivatives, seven quercetin derivatives and a
narigenin derivative. Peaks 25 (quercetin-3-O-rutinoside), 34 (kaemp-
ferol-3-O-rutinoside), 36 (quercetin-3-O-glucoside) and 39 (narigenin-
7-O-glucoside), were positively identiﬁed according to their retention
time and UV and mass spectra, in comparison with commercial stan-
dards.
Compounds 28, 29, 33, 43, 47, 48, 49 and 50 were identiﬁed as
kaempferol glycoside derivatives owing to the product ion observed at m/z
285 and UV spectra (λmax around 348 nm). Compound 28 ([M-H]− at m/z
765) presented two MS2 fragments, revealing the alternative loss of acet-
ylglucuronyl (m/z at 547;−42–176 u) and malonylglucuronyl (m/z at 285;
−86–176 u) residues, indicating location of each residue on diﬀerent posi-
tions of the aglycone. For compound 29 ([M-H]− at m/z 739) only one MS2
fragment was present (m/z at 285; −146-146–162 u) suggesting that the
three sugars were linked together. No information about the identity of the
sugar moieties and location onto the aglycone could be obtained, so, these
compounds were tentatively identiﬁed as kaempferol-O-acetylglucuronyl-O-
malonylglucuronide and kaempferol-O-deoxyhexosyl-(deoxyhexosyl-hexo-
side), respectively. Mass characteristics of peak 47 ([M-H]− at m/z 609), 43
and 49 ([M-H]− at m/z 637) indicated that these compounds corresponds to
kaempferol derivatives bearing two hexosyl (-162–162 u) and glucuronyl
(-176–176 u) residues, respectively. The observation of only one MS2 frag-
ment at m/z 285, also indicated that the residue moieties were linked to-
gether. Thus, these compounds were tentatively identiﬁed as kaempferol-O-
dihexoside and kaempferol-O-diglucuronide. Similarly, compounds 48 ([M-
H]− atm/z 607) and 50 ([M-H]− atm/z 591), also released one fragment at
m/z 285, from the respective losses of deoxyhexosyl-glucuronide (322 u) and
acetylpentosyl-pentoside (306 u) moieties, thus being tentatively assigned as
kaempferol-O-deoxyhexosyl-glucuronide and kaempferol-O-acetylpentosyl-
pentoside. Compound 33 presented the same molecular weight as compound
34 (kaempferol-3-O-rutinoside), but with an earlier retention time, thus being
assigned to kaempferol-O-deoxyhexosyl-hexoside.
Compounds 20, 24, 31, 37 and 41 were identiﬁed as quercetin
glycosides derivatives based on their UV spectra (λmax around 350 nm)
and the production of a MS2 fragment ion at m/z 301. Tentative iden-
tities of these compounds were assigned based on their pseudomole-
cular ions using a similar reasoning as for kaempferol derivatives. Thus,
compound 20 ([M-H]− at m/z 755), 24 and 31 ([M-H]− at m/z 609)
could correspond to quercetin-O-dideoxyhexosyl-hexoside and quer-
cetin-O-deoxyhexosyl-hexoside, respectively, whereas peaks 37 ([M-
H]− at m/z 597) and 41 ([M-H]− at m/z 623) should correspond to
quercetin-O-deoxyhexosyl-pentoside and quercetin-O-deoxyhexosyl-
glucuronide, respectively.
Peaks 20, 25, 29, 33, 34 and 36, correspond to diﬀerent quercetin
and kaempferol glycosides that have been previously described in G.
robertianum (Fodorea et al., 2005; Graça et al., 2016b; Ivancheva and
Petrova, 2000; Kartnig and Bucar-Stachel, 1991; Kobakhidze and
Alaniya, 2004).
Twelve phenolic acids were detected, ﬁve hydroxybenzoic acids
(compounds 3, 11, 13, 40 and 42) and seven hydroxycinnamic acid and
derivatives (compounds 1, 4, 5, 7, 10, 16 and 22). Protocatechuic acid
(compound 3), 5-O-caﬀeoylquinic acid (compound 5), p-hydro-
xybenzoic acid (compound 11), vanillic acid (compound 13), p-cou-
maric acid (compound 22) were positively identiﬁed according to their
retention time and UV and mass spectra, in comparison with com-
mercial standards. 3-O-Caﬀeoylquinic acid (compound 1), 3-p-cou-
maroylquinic acid (compound 4), 3-O- and 4-O-feruloylquinic acids
(compounds 7 and 10, respectively), were tentatively identiﬁed taking
into account their fragmentation pattern and relative intensities similar
to those reported by Cliﬀord et al. (2003) and Cliﬀord et al. (2005).
Compound 16 ([M-H]− at m/z 335) was tentatively identiﬁed as a
caﬀeoylshikimic acid due to its similar fragmentation pattern described
by Al-Ayed (2015) and Bastos et al. (2007). Compounds 40 ([M-H]− at
m/z 625) and 42 ([M-H]− at m/z 591), both produced a major MS2
fragment ion at m/z 301, which can be interpreted as corresponding to
deprotonated ellagic acid; in the case of compound 40, it lost two
hexosyl moieties (–324 u), which was tentatively identiﬁed as an ellagic
acid dihexoside. No full identity was obtained for compound 42, being
assigned as ellagic acid derivative. Moreover, no tentative identiﬁcation
was possible to achieve for compounds 44, 45 and 46, remaining as
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unknown compounds. 5-O-Caﬀeoylquinic acid, 3-O-caﬀeoylquinic acid,
p-coumaric acid have been reported in some Geranium species Paun
et al., 2011, 2012; Tuominen, 2013; Tuominen et al., 2013).
In this work, the lower compositional complexity of the fractions
obtained compared with the whole extracts turned possible the iden-
tiﬁcation of more than two dozens of compounds, mostly quercetin and
kampferol glycosides, phenolic acids and galloyl tannins (Table 1),
which, to the best of our knowlege, have not hitherto been reported in
G. robertianum.
3.2. Evaluation of bioactivity of the fractions
The antioxidant properties of the fractions obtained from the most
bioactive extracts of G. robertianum (EtOAc, acetone and MeOH) were
evaluated by three diﬀerent assays: DPPH radical scavenging capacity,
reducing power and β-carotene bleaching inhibition. The results are
shown in Table 5. The cytotoxic activities of the same fractions were
tested against four human tumor cell lines (i.e., MCF-7, NCI-H460,
HeLa and HepG2) and in a non-tumor primary culture (porcine liver
primary cell culture). The results are presented in Table 5.
Table 1
Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, tentative identiﬁcation of phenolic compounds of the extracts of Geranium
robertianum L.
Peak Rt (min) λmax (nm) Molecular ion [M-
H]− (m/z)
MS2 (m/z) Tentative identiﬁcation Ethyl
Acetate
Acetone Metanol
1 4.88 328 353 191(64),179(32),161(3),135(40) 3-O-Caﬀeoylquinic acid d d d
2 4.57 276 483 331(13),313(23),271(11),169(6) Digalloyl-glucose nd d nd
3 5.76 260,sh294 153 109(100) Protocatechuic acida d nd d
4 6.52 312 337 191(4),173(5),163(100),119(50) 3-p-Coumaroylquinic acida nd d d
5 7.01 320 353 191(100),179(5),173(6), 161(5), 135(5) 5-O-Caﬀeoylquinic acid d nd d
6 7.37 224/sh286 815 797(25),753(8),725(6),301(60) Unknown ellagitannin nd d nd
7 7.56 323 367 193(100),191(3),173(3),148(6),134(4),107(50) 3-O-Feruloylquinic acida d d d
8 8.01 274 633 463(34),301(100) Galloyl-HHDP-glucose nd d d
9 8.16 278 635 483(6),465(100),313(26),295(5),169(5) Trigalloyl-glucose nd d nd
10 8.66 328 367 193(22),191(21),173(3),161(100),135(13) 4-O-Feruloylquinic acida nd nd d
11 8.69 256 137 93(100) p-Hydroxybenzoic acida d nd nd
12 9.63 278 635 483(6),465(100),313(26),295(5),169(5) Trigalloyl-glucose nd nd d
13 10.35 261,sh292 167 108(100) Vanillic acida d nd nd
14 11.42 270 951 933(70),633(3),481(3),451(4),301(39) Geraniin isomer 1 nd d d
15 12.53 270 951 933(70),633(3),481(3),451(4),301(39) Geraniin isomer 2a nd d nd
16 12.76 326 335 179(100),135(16) Caﬀeoylshikimic acid d nd nd
17 12.81 284 635 483(11),465(35),343(17),295(5),169(20) Trigalloyl-glucose nd d nd
18 13.12 270 951 933(70),633(3),481(3),451(4),301(39) Geraniin isomer 3a nd d nd
19 14.31 280 785 483(12),301(100) Digalloyl-HHDP-glucose nd d nd
20 14.83 356 755 301(100) Quercetin-O-dideoxyhexosyl-hexoside d d d
21 14.88 280 787 635(22),617(12),465(4),169(13) Tetragalloyl-glucose d d d
22 15.18 310 163 119(100) p-Coumaric acid d nd d
23 15.77 280 787 635(22),617(12),465(4),169(13) Tetragalloyl-glucosea nd d nd
24 15.97 350 609 301(100) Quercetin-O-deoxyhexosyl-hexosidea nd d d
25 16.37 354 609 301(100) Quercetin-3-O-rutinoside d d d
26 16.39 278 785 633(5),615(5),483(15),301(84),275(6) Digalloyl-HHDP-glucose nd d nd
27 16.82 280 787 635(5),617(100),465(7),169(5) Tetragalloyl-glucose nd d d
28 16.95 348 765 547(26),285(100) Kaempferol-O-acetylglucuronyl-O-
malonylglucuronidea
d nd nd
29 17.19 350 739 285(100) Kaempferol-O-dideoxyhexosyl-
hexoside
d d d
30 18.08 226/sh280 933 915(12),765(10),631(3),613(3),463(10),301(42) Castalagin/Vescalagin nd d nd
31 18.15 353 609 301(100) Quercetin-O-deoxyhexosyl-hexosidea d d d
32 18.18 277 935 633(6),301(21) Galloyl-bis-HHDP-glucosea nd d nd
33 18.77 350 593 285(100) Kaempferol-O-deoxyhexosyl-hexoside d d d
34 18.82 350 593 285(100) Kaempferol-3-O-rutinoside d d nd
35 19.3 269/sh365 939 787(3),769(76),617(9),465(3) Pentagalloyl glucosea nd d nd
36 19.32 358 463 301(100) Quercetin-3-O-glucoside nd nd d
37 19.63 347 579 301(100) Quercetin-O-deoxyhexosyl-pentosidea nd nd d
38 20.64 280 935 917(16),767(21),749(11),465(8),301(23) Unknown ellagitannin nd d nd
39 21.3 283 433 271(100) Naringenin−7-O-glucosidea d nd nd
40 21.85 370 625 301(100) Ellagic acid dihexosidea nd nd d
41 23.09 355 623 301(100) Quercetin-O-deoxyhexosyl-
glucuronidea
d nd d
42 23.26 365 591 301(100),179(50),151(30) Ellagic acid derivative nd d nd
43 24.34 340 637 285(100) Kaempferol-O-diglucuronidea nd nd d
44 24.69 312 433 307(100) Unknown d nd d
45 24.87 259/sh305 579 459(13),441(73),289(100),169(86) Unknown nd nd d
46 25.42 307 433 307(100) Unknown d nd nd
47 25.85 351 609 285(100) Kaempferol-O-dihexosidea nd nd d
48 27.25 351 607 285(100) Kaempferol-O-deoxyhexosyl-
glucuronidea
d nd d
49 30.94 349 637 285(100) Kaempferol-O-diglucuronidea nd nd d
50 31.48 348 591 285(100) Kaempferol-O-acetylpentosyl-
pentosidea
nd nd d
d − detected. nd − not detected.
a Hitherto unreported in G. robertianum.
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Table 2
Quantiﬁcation of phenolic compounds present in the fractions of ethyl acetate extract of Geranium robertianum L.a.
Peak Tentative identiﬁcation FEA5 FEA6 FEA7 FEA8 FEA9 FEA10
mg/g
1 3-O-Caﬀeoylquinic acid – – – – – 1.335 ± 0.006
3 Protocatechuic acid – 0.137 ± 0.002 0.23 ± 0.01 0.1302 ± 0.0007 – –
5 5-O-Caﬀeoylquinic acid – – – 0.259 ± 0.003 – –
7 3-O-Ferulouylquinic acid – – – 0.2425 ± 0.0009 – –
11 p-Hydroxybenzoic acid 2.67 ± 0.02 0.399 ± 0.009 0.173 ± 0.008 – – –
13 Vanillic acid 0.348 ± 0.007 – – – – –
16 Caﬀeoylshikimic acid – tr – – – –
20 Quercetin-O-dideoxyhexosyl-hexoside – – – 0.8924 ± 0.0001 – –
21 Tetragalloyl-glucose – – – – 2.636 ± 0.001 –
22 p-Coumaric acid 0.65 ± 0.01 tr – – – –
25 Quercetin-3-O-rutinoside – – – tr tr –
28 Kaempferol-O-acylglucuronyl-O-malonylglucuronide – tr – – – –
29 Kaempferol-O-dideoxyhexosyl-hexoside – – – – tr –
31 Quercetin-O-deoxyhexosyl-hexoside – – – 0.8916 ± 0.0001 – –
33 Kaempferol-O-deoxyhexosyl-hexoside – – – tr –
34 Kaempferol-3-O-rutinoside – – – – tr –
39 Naringenin-7-O-glucoside – tr – – – –
41 Quercetin-O-deoxyhexosyl-glucuronide – – – 0.9250 ± 0.0009 0.9421 ± 0.0004 –
44 Unknown – – – – – –
46 Unknown – – – – – –
48 Kaempferol-O-deoxyhexosyl-glucuronide – 2.32 ± 0.05 – tr tr 1.28 ± 0.02
TPA 3.66 ± 0.04 0.536 ± 0.007 0.404 ± 0.004 0.631 ± 0.003 – 1.335 ± 0.006
TED – – – – 2.6365 ± 0.0008 –
TF – 2.32 ± 0.05 – 2.7090 ± 0.0009 0.9421 ± 0.0004 1.28 ± 0.02
TPC 3.66 ± 0.04 2.85 ± 0.04 0.483 ± 0.002 3.341 ± 0.004 3.579 ± 0.001 2.61 ± 0.03
TPA − Total phenolic acids. TED − Total ellagitannins derivate. TF − Total ﬂavonoids. TPC − Total phenolic compounds. FEA − fractions of ethyl acetate extract.
a Fractions FEA1, FEA2, FEA3 and FEA4 did not present phenolic compounds.
Table 3
Quantiﬁcation of phenolic compounds present in the fractions of acetone extract of Geranium robertianum L.a.
Peak Tentative identiﬁcation FA4 FA5 FA6 FA7 FA8 FA9 FA10 FA11
mg/g
1 3-O-Caﬀeoylquinic acid – – 0.36 ± 0.01 3.3 ± 0.05 11.5 ± 0.5 1.98 ± 0.05 0.60 ± 0.01 –
2 Digalloyl-glucose 2.84 ± 0.02 4.22 ± 0.03 – – – – – –
4 3-p-Coumarouylquinic acid – – – 0.40 ± 0.01 – – – –
6 Unknown ellagitannin 4.3 ± 0.1 2.77 ± 0.04 2.57 ± 0.04 – – – – –
7 3-O-Ferulouylquinic acid – – – 0.352 ± 0.001 1.4 ± 0.0 – – –
8 Galloyl-HHDP-glucose – – – – – – – 4.09 ± 0.03
9 Trigalloyl-glucose 5.82 ± 0.06 3.1 ± 0.1 – – – – – –
14 Geraniin isomer 1 9.3 ± 0.2 28.6 ± 0.4 7.68 ± 0.07 7.2 ± 0.1 15.1 ± 0.6 – – 7.69 ± 0.25
15 Geraniin isomer 2 – – 4.94 ± 0.01 4.89 ± 0.07 – – – –
17 Trigalloyl-glucose 3.37 ± 0.03 – – – – – – –
18 Geraniin isomer 3 – 2.68 ± 0.05 3.51 ± 0.04 3.4 ± 0.1 – – – –
19 Digalloyl-HHDP-glucose 4.44 ± 0.03 2.68 ± 0.04 – – – – – –
20 Quercetin-O-dideoxyhexosyl-hexoside – – – – 2.39 ± 0.03 – – –
21 Tetragalloyl-glucose 6.13 ± 0.05 3.15 ± 0.02 – – – – – –
23 Tetragalloyl-glucose 4.08 ± 0.07 3.96 ± 0.04 – – – – – –
24 Quercetin-O-deoxyhexosyl-hexoside – – – 1.16 ± 0.01 1.085 ± 0.004 – – –
25 Quercetin-3-O-rutinoside – – – 3.39 ± 0.06 tr – – –
26 Digalloyl-HHDP-glucose 3.81 ± 0.02 – – – – – – –
27 Tetragalloyl-glucose 7.6 ± 0.3 4.10 ± 0.04 – – – – – –
29 Kaempferol-O-dideoxyhexosyl-
hexoside
– – – 0.04 ± 0.00 1.054 ± 0.001 – – –
30 Castalagin/Vescalagin 23.6 ± 0.6 31.5 ± 0.1 7.0 ± 0.2 – – – – –
31 Quercetin-O-deoxyhexosyl-hexoside – – – 1.96 ± 0.04 – – – –
32 Galloyl-bis-HHDP-glucose – – – – 15.5 ± 0.3 – – 7.58 ± 0.03
33 Kaempferol-O-deoxyhexosyl-hexoside – – – 2.61 ± 0.07 – – – –
34 Kaempferol-3-O-rutinoside – – – 1.63 ± 0.02 – – – –
35 Pentagalloyl glucose 3.4 ± 0.1 7.03 ± 0.08 – – – – – –
38 Unknown ellagitannin 5.2 ± 0.1 3.48 ± 0.02 – – – – – –
42 Ellagic acid derivative 7.3 ± 0.2 – – – – – – –
TPA – – 0.36 ± 0.01 4.1 ± 0.1 12.9 ± 0.5 1.98 ± 0.05 0.60 ± 0.01 –
TED 91 ± 1 97.3 ± 0.3 25.67 ± 0.02 15.5 ± 0.3 30.7 ± 0.3 – – 19.35 ± 0.31
TF – – – 10.8 ± 0.2 4.53 ± 0.03 – – –
TPC 91 ± 1 97.3 ± 0.3 26.03 ± 0.03 30.4 ± 0.5 48.1 ± 0.9 1.98 ± 0.05 0.60 ± 0.01 19.35 ± 0.3
TPA − Total phenolic acids. TED − Total ellagitannins derivate. TF − Total ﬂavonoids. TPC − Total phenolic compounds. FA − fractions of acetone extract.
a Fractions FA1, FA2 and FA3 did not present phenolic compounds.
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In general all fractions resulting from the acetone extract (FA1-
FA11) exhibited bioactivity. The most bioactive ones were FA4, FA5
and FA8, which also presented the higher contents of total phenolic
compounds (91.0, 97.3 and 48.1 mg/g, respectively, Table 3) when
compared to the other fractions. Amongst those, fraction FA4 displayed
particularly low hepatotoxicity (IC50 > 400 μg/mL).
Fractions FA4 and FA5 showed to contain only ellagitannins and the
higher amount of these group of compounds among all the tested
fractions. Compound 30, which was tentatively identiﬁed as castalagin
or vescalagin, was the main compound of these fractions (23.6 mg/g in
FA4 and 31.5 mg/g in FA5, Table 3). The antioxidant and cytotoxic
properties of both castalagin and vescalagin have been previously de-
scribed (Fernandes et al., 2009; Fridrich et al., 2008; Jordão et al.,
2012). In each of the fractions FA4, FA5 and FA8 compound 14, an
isomer of geraniin, was the second most abundant compound present
(9.3, 26.6 and 15.1 mg/g, respectively, Table 3). Geraniin has been
described as the main phenolic compound in various Geranium species
(Harborne and Williams, 2002; Okuda et al., 1980, 1979, 2000;
Piwowarski et al., 2014; Tuominen, 2013; Tuominen et al., 2013; Wu
et al., 2011) and is endowed with several beneﬁcial biological activities
(Cheng et al., 2017). Apart from the identiﬁed ellagitannins, FA8
showed to contain also some phenolic acids and ﬂavonoids. In this
fraction, compound 32, tentatively identiﬁed as galloyl-bis-HHDP-glu-
cose, was the main compound present (15.5 mg/g, Table 3).
The MeOH extract fractionation resulted in thirteen fractions (FM1-
13). In general, all of them possessed biological activity. FM3 and FM4
were the fractions that exhibited, simultaneously, the best antioxidant
and cytotoxic activities. FM2 also exhibited good cytotoxic activity but
poor/moderate antioxidant activity, except for the DPPH assay. FM4
showed additionally the highest content of total phenolic compounds
(63.9 mg/g, Table 4), but this direct relation activity/content of phe-
nolic compounds was not observed for the remaining more bioactive
fractions.
Fraction FM2 possessed approximate amounts of ellagitannins and
ﬂavonoids (11.43 and 9.30 mg/g, respectively, Table 4), and also some
phenolic acids (2.23 mg/g, Table 4). Compound 48, which was tenta-
tively identiﬁed as kaempferol-O-deoxyhexosyl-glucuronide, was the
main compound detected (4.78 mg/g, Table 4). Several biological
properties, including antioxidant and antiproliferative activities, of
diﬀerent kaempferol glycosides has been previously reported
(Calderón-Montaño et al., 2011; Xiao et al., 2014). The second most
abundant compound in this fraction was tetragalloyl-glucose (com-
pound 27) The biological activity of this compound has been described
(Sugimoto et al., 2009; Xiang et al., 2010; Zhang et al., 2009). FM3
showed to be constituted by phenolic acids, ﬂavonoids and ellagitannin
derivatives, this later group being the most abundant (13.1 mg/g,
Table 4). Fraction FM4 consisted mainly of ellagitannin derivatives
(57.8 mg/g, Table 4), together with a small amount of ﬂavonoids
(6.06 mg/g, Table 4). Compound 14 (geraniin isomer 1) was the most
abundant in both fractions FM3 and FM4 (5.1 and 38.7 mg/g, respec-
tively, Table 4).
Fractions FM7, FM8, FM11 and FM12 displayed high antioxidant
activity but no relevant cytotoxic activity. With the exception of FM7,
for which phenolic acids were the major constituents, in all the other
fractions ellagitannin derivatives were the most abundant compounds.
The major compound found in FM7 was tentatively identiﬁed as 3-O-
caﬀeoylquiic acid (compound 1), while for the remaining fractions
geraniin isomer 1 (compound 14) was the most abundant compound
(Table 4).
The EtOAc extract yielded, after fractionation, eleven fractions
(FEA1-11). However, the color of fractions FEA1-FEA4 did not allow
the study of their bioactivity, most probably due to the presence of
chlorophylls or other pigments. The remaining fractions of this extract
possessed antioxidant activity much lower than that of the fractions
resulting from the acetone and MeOH extracts. Fractions FEA5, FEA6
and FEA8 showed moderate cytotoxicity. Fraction FEA5 showed toT
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contain only phenolic acids and, at the same time, the higher amount of
this phenolic group among all the tested fractions. The major compound
found in this fraction was p-hydroxybenzoic acid (compound 11,
Table 2). Fractions FEA6 and FEA8 showed to contain, apart from
phenolic acids, ﬂavonoids as the main phenolic compounds. In both
fractions, the most abundant compounds were derivatives of quercetin
and kaempferol (Table 2).
The bioactivity of several fractions was found to be higher, in some
cases considerably, than that of the corresponding extract. However, for
the majority of fractions the bioactivity was lower what seems to point
to a synergistic eﬀect of the mixture of compounds present in the ex-
tract. In a number of fractions the hepatotoxicity displayed GI50 values
higher than 400 mg/mL, while for the whole extracts GI50 values
ranged from 176 to 290 mg/mL.
3.3. Correlation between the phenolic proﬁle and the bioactivity of the
fractions
The relationship between the sample’s cytotoxic and antioxidant
properties and the phenolic composition was established based on the
correlation factors between total phenolic acids, total ellagitannin de-
rivatives, total ﬂavonoids and total phenolic compounds, and the EC50
and GI50 values found, respectively, for the antioxidant and cytotoxic
activities (Table 6). In what concerns the fractions obtained from the
EtOAc extract, there seems to exist no relevant correlation between
phenolic composition and antioxidant activity. However, the cytotoxic
activity of these fractions was correlated signiﬁcantly with total ﬂavo-
noids (r2 =−0.814, −0.834 and −0.739, for the NCI-H460, HepG2
and PLP2 cell lines, respectively). The total phenolic compounds of
Table 5
Bioactive properties of diﬀerent fractions of ethyl acetate, acetone and methanol extracts of Geranium robertianum L.
Antioxidant activity (EC50, μg/mL) Antiproliferative activity (GI50, μg/mL) Hepatotoxicity (GI50, μg/mL)
Fractions DPPH Reducing power β-Carotene/linoleic acid MCF-7 NCI-H460 HeLa HepG2 PLP2
FEA1 nd nd nd nd nd nd nd nd
FEA2 nd nd nd nd nd nd nd nd
FEA3 nd nd nd nd nd nd nd nd
FEA4 nd nd nd nd nd nd nd nd
FEA5 119.0 ± 0.3e 974 ± 2c 945 ± 61c 92 ± 1d 51 ± 4e 96 ± 7d 92 ± 10e 128 ± 5c
FEA6 302 ± 5d 232 ± 6e 448 ± 43c 54 ± 2f 119 ± 2d 34 ± 3e 72 ± 3e 238 ± 20b
FEA7 614 ± 3c 396 ± 2d 509 ± 43c 90 ± 5d 243 ± 17b 89 ± 2d 237 ± 26a > 400
FEA8 2777 ± 35a 3617 ± 77a 1628 ± 146b 82 ± 6e 169 ± 6c 88 ± 2d 83 ± 5e 235 ± 9b
FEA9 1516 ± 128b 1591 ± 6b 15128 ± 943a 110 ± 7c 232 ± 19b 115 ± 8c 125 ± 15d 302 ± 20a
FEA10 260 ± 12d 179 ± 8f 529 ± 59c 188 ± 1b 236 ± 23b 186.4 ± 0.4b 153 ± 5c > 400
FEA11 271 ± 7d 171 ± 9f 610 ± 16c 234 ± 2a 304 ± 18a 236 ± 6a 207 ± 11b > 400
p-values (n = 21)
Homoscedasticity1 < 0.001 < 0.001 < 0.001 0.246 0.337 0.256 0.252 0.071
1-way ANOVA2 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
FA1 4062 ± 75b 690 ± 12b 1577 ± 67a 87 ± 4 cd 240 ± 15a 87 ± 4c 93 ± 9 cd 286 ± 15a
FA2 9903 ± 18a 774 ± 7a 1530 ± 52a 195 ± 22b 251 ± 17a 223 ± 12a 164 ± 13b > 400
FA3 1152 ± 17c 648 ± 9c 734 ± 57b 91 ± 8c 98 ± 1bc 71 ± 1d 251 ± 26a 196 ± 16b
FA4 52 ± 3g 31.2 ± 0.1j 61 ± 5e 237 ± 7a 72 ± 7 cd 39 ± 4d 56 ± 3e > 400
FA5 44 ± 1g 32.1 ± 0.2j 67.4 ± 0.2e 48 ± 9d 61.9 ± 0.4d 67 ± 3d 50 ± 2e 127 ± 12e
FA6 57 ± 2g 179 ± 6f 226 ± 9c 48 ± 8d 231 ± 16a 90 ± 3c 74 ± 4de 172 ± 18bcd
FA7 119 ± 1f 89 ± 5h 125 ± 7d 67 ± 6 cd 92 ± 6bc 61 ± 1d 60 ± 4e 151 ± 10de
FA8 112 ± 3f 46.9 ± 0.3i 35 ± 1e 62 ± 3 cd 117 ± 2b 60 ± 6d 63 ± 2e 167 ± 16 cd
FA9 553 ± 14d 269 ± 9e 195 ± 5c 191 ± 18b 244 ± 18a 171 ± 10b 170 ± 17b > 400
FA10 439 ± 37e 285 ± 2d 239 ± 12c 264 ± 8a 247 ± 20a 215 ± 11a 267 ± 23a > 400
FA11 139 ± 2f 108 ± 2g 155 ± 1d 77 ± 7 cd 259 ± 21a 102 ± 12c 101 ± 4c 191 ± 12bc
p-values (n = 33)
Homoscedasticity1 < 0.001 < 0.001 < 0.001 0.089 0.242 0.236 0.110 0.072
1-way ANOVA2 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
FM1 13471 ± 916a 1595 ± 16a 1590 ± 53a 95 ± 6c 269 ± 16d 138 ± 13e 116 ± 11d 322 ± 33b
FM2 63 ± 2c 147 ± 8e 913 ± 65b > 400 59 ± 4g 53 ± 6g 52 ± 4e > 400
FM3 23 ± 1c 51.5 ± 0.1ij 23 ± 1hi 74 ± 1c 170 ± 2e 77 ± 1f 67 ± 7e 207 ± 10c
FM4 17.2 ± 0.3c 44.6 ± 0.7j 7.0 ± 0.5i 78 ± 1c 123 ± 8f 78 ± 1f 65 ± 6e 166 ± 13d
FM5 53 ± 1c 95 ± 1f 207 ± 11e 247 ± 9a 323 ± 27ab 258 ± 1ab 215 ± 8c > 400
FM6 98 ± 6c 188 ± 3c 281 ± 12d 213 ± 12ab 311 ± 23bc 233 ± 4c 241 ± 12b > 400
FM7 26 ± 2c 63 ± 8gh 101 ± 10f 189 ± 24b 279 ± 18 cd 203 ± 20d 103 ± 8d > 400
FM8 49 ± 1c 65.7 ± 0.4g 85 ± 1fg 188 ± 30b 353 ± 11a 241 ± 5bc 205 ± 9c > 400
FM9 82 ± 1c 171 ± 3d 89 ± 9fg 223 ± 17ab > 400 270 ± 3a 259 ± 15b > 400
FM10 132 ± 1c 232 ± 4b 509 ± 4c 250 ± 1a 332 ± 22ab 265 ± 15a 252 ± 14b > 400
FM11 26.0 ± 0.5c 33 ± 1k 69 ± 4fg 222 ± 12ab 264 ± 7d 255 ± 18ab 103 ± 5d > 400
FM12 36.5 ± 0.4c 51 ± 1ij 52.9 ± 0.5gh 197 ± 9b 305 ± 22bc 204 ± 10d 104 ± 12d 367 ± 27a
FM13 569 ± 9b 56 ± 1hi 213 ± 13e 178 ± 15b 353 ± 21a 200 ± 5d 293 ± 16a > 400
p-values (n = 39)
Homoscedasticity1 < 0.001 < 0.001 < 0.001 0.016 0.324 0.112 0.874 0.006
1-way ANOVA2 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
FEA − fractions of ethyl acetate extract; FA − fractions of acetone extract; FM − fractions of methanol extract; nd − not determined. The antioxidant activity was expressed as EC50
values, what means that higher values correspond to lower reducing power or antioxidant potential. EC50: Extract concentration corresponding to 50% of antioxidant activity or 0.5 of
absorbance in reducing power assay. Trolox EC50 values: 41 μg/mL (reducing power), 42 μg/mL (DPPH scavenging activity) and 18 μg/mL (β-carotene bleaching inhibition). GI50 values
correspond to the sample concentration achieving 50% of growth inhibition in human tumor cell lines or in liver primary culture PLP2. Ellipticine GI50 values: 1.21 μg/mL (MCF-7),
1.03 μg/mL (NCI-H460), 0.91 μg/mL (HeLa), 1.10 μg/mL (HepG2) and 2.29 μg/mL (PLP2).
1 Homoscedasticity among fractions of each exctract were tested by the Levene test: homoscedasticity, p > 0.05; heteroscedasticity, p < 0.05.
2 p < 0.05 indicates that the mean value of at least one component diﬀers from the others (in this case, multiple comparison tests were performed). For each fraction, means within a
column with diﬀerent letters diﬀer signiﬁcantly (p < 0.05).
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these fractions also showed signiﬁcant correlation (r2 =−0.863) with
the toxicity against the HepG2 cell line.
Acetone fractions showed the highest correlation between total
phenolic acids and the antioxidant activity determined by the β-car-
otene/linoleic acid assay (r2 =−0.959), and a signiﬁcant correlation
(r2 =−0.784) between the total phenolic acids and the antioxidant
activity assessed by the reducing power assay. The total ellagitannin
derivatives showed good correlation with the results of the DPPH assay
(r2 =−0.778). The total phenolic compounds and the antioxidant ac-
tivity of the acetone fractions showed to be signiﬁcantly correlated
(r2 =−0.710, −0.842 and−0.801, for DPPH, reducing power and β-
carotene/linoleic acid assays, respectively). The cytotoxic eﬀects of
these fractions and the respective phenolic composition also presented
relatively good correlation factors, being the cytotoxicity displayed
against the NCI-H460 cell line correlated with total phenolic acids
(r2 =−0.704) and the cytotoxicity observed against the NCI-H460,
HeLa and HepG2 cell lines correlated with total phenolic compounds
(r2 =−0.853,−0.755 and−0.698, respectively). The activities of the
fractions obtained from the MeOH extract revealed to be poorly cor-
related with the phenolic composition. The best correlation was found
between total phenolic compounds and the cytotoxicity observed on the
HepG2 cell line (r2 =−0.69).
4. Conclusions
Following a recent work conducted by our research group in which
the bioactivity of diﬀerent organic extracts of G. robertianum was stu-
died, in this work the most bioactive extracts (EtOAC, acetone and
MeOH) were fractionated by gradient elution column chromatography.
The phenolic proﬁle of the resulting fractions was determinated and the
antioxidant and cytotoxic activities were evaluated and correlated with
the respective phenolic composition. In addition to hydrolyzable tan-
nins, the most abundant compounds found in this plant, were also
identiﬁed ﬂavonoid glycosides derivatives − mainly kaempferol and
quercetin derivatives − and phenolic acids. To the best of our knowl-
edge, about two dozen of the compounds found were identiﬁed in G.
robertianum for the ﬁrst time. In general, the fractions from the acetone
extract were those exhibiting higher bioactivity when compared with
those from the other extracts. Three fractions of acetone extract (FA4,
FA5 and FA8) displayed consistently low EC50 and GI50 values. These
fractions also presented the higher contents of total phenolic com-
pounds when compared with the other fractions. Fraction FA4
displayed particularly low hepatotoxicity (IC50 > 400 μg/mL).
Generally, the fractions resulting from the MeOH extract possessed
moderate biological activity. The EtOAc fractions presented antioxidant
activity much lower than that of the fractions resulting from the
acetone and MeOH extracts. Some of these fractions showed moderate
cytotoxicity. The acetone fractions were the ones that presented the
highest correlation factors between biological activity and phenolic
composition.
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